DIA will host DIA 2011: Converge of Science, Medicine, and Health, from June 19-23 at McCormick Place in Chicago, IL.
This year’s meeting will attract more than 8,000 attendees from 50 countries and address all the tough issues facing professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related health care products. DIA 2011 also features more than 220 sessionS across 17 tracks, including:
- Clinical Operations
- Development Planning
- Outsourcing Strategies and Innovative Partnering Models
- Nonclinical and Early Clinical Translational Development
- Product Advertising and Communications
- Medical Writing and Communications
- IT Methods and Technologies
- Research Data and Content Management
- Regulatory Affairs and Science, Quality and GXP Compliance
- Public Policy/Health Care Compliance
- Clinical Safety and Pharmacovigilance
- Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)
- New! Medical Devices
- Professional Development
- New! Global Agency
- New! SIAC Showcase
DIA 2011 is moving in a new direction in an effort to streamline the program and focus on the hottest topics. There are many expanded opportunities for people to participate, including forums, symposia, workshops, panels, sessions, executive sessions, and preconference tutorials. DIA 2011 is tailored to all types of learners.
“DIA 2011 reflects new scope areas for DIA, including medical devices and comparative effectiveness research/health technology assessment, as well as new formats that provide you with new opportunities and greater flexibility,” explains DIA Worldwide Executive Director Paul Pomerantz.
David D. Ho, MD, Founding Scientific Director and Chief Executive Officer of the Aaron Diamond AIDS Research Center
Gail R. Wilensky, PhD, Health Care Expert and Senior Fellow at Project HOPE
GLOBAL AGENCY TRACK
- Participating regulatory agencies include:
- Center for Biologics Evaluation and Research (CBER), US FDA
- Center for Devices and Radiological Health (CDRH), US FDA
- Center for Drug Evaluation and Research (CDER), US FDA
- European Heads of Medicines Agencies, European Union
- European Medicines Agency, European Union
- Health Canada, Canada
- India Town Hall, Drugs Controller of India (DCGI) and FDA Gujarat, (India)
- Latin American Agency Town Hall
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
- State Food and Drug Administration, China
- Therapeutic Goods Administration (TGA), Australia
SPECIAL PLENARY SESSION
Voice of the Patient: Stories That Touch Us
Tuesday, June 21, 8:00 AM
A panel of patients will share details about themselves along with their experience with clinical trials, what prompted their interest in participating, and the obstacles or challenges they encountered with friends and family when they told them about their participation.
PATIENT ADVOCACY FELLOWSHIP PROGRAM
DIA’s Patient Advocacy Fellowship Program enhances the participation of patient groups to develop, strengthen, and support their collaborations with policy makers, health professionals, industry representatives, and academia. Deadline for applications is February 28, 2011.
Tuesday, June 21, 3:30-4:30 PM
These special sessions allow you to learn from and network with professionals in your particular interest area. SIACs provide a discipline-specific, global community where members can share common experiences and knowledge and connect with others in their particular field. For more information on SIACs, contact Donna.Mayer@diahome.org.
“DIA 2011 is all about keeping people ‘in the know,’ opening people’s eyes to changes that are occurring, and anticipating those changes through networking and educational programs,” says Kenneth A. Getz, MBA, Senior Research Fellow, Tufts Center for the Study of Drug Development, Tufts University; Chairman, CISCRP. “It truly is the largest global, multidisciplinary gathering of biopharmaceutical professionals whose agenda is clear: to find immediate solutions to your most pressing challenges of today and tomorrow.”
DIA 2011 attracts the biggest names in the pharmaceutical, biotechnology, medical device, and related health care sectors, provides insights and inspiration on the major trends affecting the industry, and offers key networking opportunities.
DIA Welcome Reception
Monday, June 20, 5:00-6:30 PM
Save money and network with nearly 8,000 attendees at the new and improved DIA Welcome Reception, held this year in the exhibit hall. Reception is included in your registration fee.
DIA 2011 provides a perfect forum for attendees and speakers to network with and evaluate more than 500 exhibiting companies. Virtually every facet of the biopharmaceutical industry and related fields is represented by an exhibitor offering services or products in this extraordinary exhibit hall marketplace. From CROs, technology vendors to site research centers, academia and much more, the exhibit hall is one of the busiest places during the meeting.
DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org